Nexgel Revenue Jumps 100% in Fiscal Q2

Nexgel (NASDAQ:NXGL) reported Q2 2025 GAAP revenue of $2.88 million, up 100.3% year-over-year, but missed analyst expectations by 6.5% and recorded a non-GAAP EPS of -$0.42, significantly below estimates. Despite a substantial improvement in GAAP gross margin to 43.6% and a narrowed adjusted EBITDA loss, the company continued to post net losses. Management reaffirmed its full-year 2025 revenue guidance of $13 million and positive EBITDA, implying a significant acceleration is required in the second half, contingent on new product launches and contract manufacturing partnerships, with recent post-quarter financing providing some liquidity for growth initiatives.

Analysis

Nexgel's Q2 2025 results present a mixed picture of significant operational improvement coupled with substantial execution risk. While year-over-year GAAP revenue impressively doubled to $2.88 million, this figure missed analyst estimates by 6.5%, and the non-GAAP EPS of -$0.42 was a severe miss against the -$0.07 consensus. The most positive development is the dramatic expansion of GAAP gross margin to 43.6% from 20.3% a year prior, validating the strategic shift towards higher-margin branded consumer products and partnerships like the one with STADA. However, this progress is tempered by continued net losses and extremely slow sequential revenue growth, which increased by only $0.07 million from Q1 2025. Management's reaffirmation of the $13 million full-year revenue guidance and a target for positive non-GAAP EBITDA appears highly ambitious, as it requires generating over $7 million in the second half of the year. While a post-quarter financing of $2.05 million alleviates immediate liquidity concerns, the company's ability to achieve its targets now hinges entirely on a steep, unproven acceleration driven by new product launches and customer onboarding in the latter half of the year.

Key Decisions for Investors

• Investors should closely monitor second-half revenue for the significant acceleration required to meet the $13 million annual guidance, as achieving this target would validate the company's growth strategy and margin expansion narrative.
• Given the substantial miss on earnings per share and stagnant sequential revenue growth, a cautious stance is warranted until there is concrete evidence of a top-line ramp-up and a clear path to sustained profitability.
• Pay close attention to cash burn and operating expenses in the upcoming quarters, as the recent $2.05 million financing provides a temporary runway, but further capital raises could be necessary if profitability targets are not met.